Loading...

APC/Cyanine7 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_APCCyanine7_CD45_Antibody_013019_updated.png
C57BL/6 splenocytes were stained with CD45 (clone 30-F11) APC/Cyanine7 (filled histogram) or Rat IgG2b, κ APC/Cyanine7 isotype control (open histogram).
  • 30-F11_APCCyanine7_CD45_Antibody_013019_updated.png
    C57BL/6 splenocytes were stained with CD45 (clone 30-F11) APC/Cyanine7 (filled histogram) or Rat IgG2b, κ APC/Cyanine7 isotype control (open histogram).
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
103115 25 µg $98
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103116 100 µg $196
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Ren Y, et al. 2021. Am J Transplant. 21:552. PubMed
  2. Hilfenhaus G, et al. 2021. Cancer Res. 81:619. PubMed
  3. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  4. Cohen K, et al. 2021. Cell Rep. 37:110026. PubMed
  5. Schnell A, et al. 2021. Cell. 184:6281. PubMed
  6. He D, et al. 2022. Immunity. 55:159. PubMed
  7. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  8. Goncharov NV, et al. 2022. J Evol Biochem Physiol. 58:230. PubMed
  9. Li DD, et al. 2022. J Cell Mol Med. 26:2438. PubMed
  10. Denorme F, et al. 2022. J Clin Invest. 132: . PubMed
  11. Tang Q, et al. 2022. Mol Ther. 30:2709. PubMed
  12. Chae CS, et al. 2022. Cancer Discov. 12:1904. PubMed
  13. Miyao T, et al. 2022. Elife. 11: . PubMed
  14. Serra M, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:609. PubMed
  15. Poh AR, et al. 2022. Sci Adv. 8:eabl7882. PubMed
  16. Campisi L, et al. 2022. Nature. 606:945. PubMed
  17. Kenigsbuch M, et al. 2022. Nat Neurosci. 25:876. PubMed
  18. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  19. Li F, et al. 2022. Gut Microbes. 14:2096989. PubMed
  20. Rodrigues PB, et al. 2022. Cells. 11: . PubMed
  21. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  22. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  23. Zhu X, et al. 2023. Adv Mater. 35:e2207198. PubMed
  24. Li S, et al. 2022. Nat Commun. 13:7371. PubMed
  25. Morrow RJ, et al. 2022. Cells. 11: . PubMed
  26. Liu P, et al. 2023. Clin Immunol. 246:109212. PubMed
  27. Alula KM, et al. 2023. Sci Rep. 13:18. PubMed
  28. Peng Q, et al. 2023. EMBO Rep. 24:e56034. PubMed
  29. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  30. Zhou J, et al. 2023. Nutrients. 15: . PubMed
  31. Slusarczyk P, et al. 2023. Elife. 12: . PubMed
  32. Cao Y, et al. 2023. J Inflamm Res. 16:343. PubMed
  33. Tsioti I, et al. 2023. J Neuroinflammation. 20:25. PubMed
  34. Li XF, et al. 2023. J Exp Med. 220: . PubMed
  35. Chun J, et al. 2023. Cancers (Basel). 15: . PubMed
  36. Drummer C, et al. 2023. Front Immunol. 14:1113883. PubMed
  37. Ishikawa T, et al. 2023. Bio Protoc. 13:e4588. PubMed
  38. Ryan CB, et al. 2022. Neurobiol Dis. 163:105608. PubMed
  39. Marsh SE, et al. 2022. Nat Neurosci. 25:306. PubMed
  40. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  41. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  42. Korsunsky I, et al. 2022. Med. 3:481. PubMed
  43. Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed
  44. Pattwell SS, et al. 2022. Sci Adv. 8:eabo6789. PubMed
  45. Schroeter CB, et al. 2022. J Neuroinflammation. 19:270. PubMed
  46. Ho HM, et al. 2022. Pharmaceutics. 14:. PubMed
  47. Cai Z, et al. 2023. Adv Sci (Weinh). 10:e2207155. PubMed
  48. Banerjee K, et al. 2023. Eur J Immunol. 53:e2250161. PubMed
  49. Wu Z, et al. 2023. EMBO Rep. 24:e56524. PubMed
  50. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  51. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  52. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  53. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  54. Saha S, et al. 2023. Sci Rep. 13:4609. PubMed
  55. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  56. Freitag PC, et al. 2023. Mol Ther Methods Clin Dev. 29:120. PubMed
  57. Thai LM, et al. 2023. iScience. 26:106477. PubMed
  58. He Q, et al. 2023. Parasit Vectors. 16:139. PubMed
  59. Sasaki L, et al. 2022. Nat Aging. 2:105. PubMed
  60. Haensel D, et al. 2023. Nat Commun. 14:2685. PubMed
  61. Lee K, et al. 2023. JCI Insight. 8:. PubMed
  62. Wang C, et al. 2023. Int J Oral Sci. 15:19. PubMed
  63. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  64. Scieszka DP, et al. 2023. Respir Res. 24:138. PubMed
  65. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  66. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  67. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  68. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  69. Stefkovich M, et al. 2021. Mol Metab. 54:101357. PubMed
  70. Wang Q, et al. 2020. Radiat Environ Biophys. 59:89. PubMed
  71. Kim MY, et al. 2021. JCI Insight. 6:. PubMed
  72. De Vries LCS, et al. 2021. J Crohns Colitis. 15:617. PubMed
  73. Bernasconi R, et al. 2021. EMBO Mol Med. :e14392. PubMed
  74. Miranda K, et al. 2022. iScience. 25:104994. PubMed
  75. Da Mesquita S, et al. 2021. Nature. 593:255. PubMed
  76. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  77. Ren D, et al. 2022. STAR Protoc. 3:101217. PubMed
  78. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  79. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  80. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  81. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  82. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  83. Naito H, et al. 2020. Nature Protocols. 15(3):1066-1081. PubMed
  84. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  85. Heindl S, et al. 2021. J Exp Med. 218:. PubMed
  86. Kokona D, et al. 2016. Exp Eye Res. S0014-4835(16)30499-7. PubMed
  87. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  88. Wu SY, et al. 2022. Mol Cancer. 21:84. PubMed
  89. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  90. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  91. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
  92. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  93. Page N, et al. 2018. Immunity. 48:937. PubMed
  94. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  95. Ajina R, et al. 2019. Oncoimmunology. 8:e1577127. PubMed
  96. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  97. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  98. Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed
  99. Urban SK, et al. 2020. Liver Int. 40:3103. PubMed
  100. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  101. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  102. Radovanovic I, et al. 2014. J Immunol. 193:1290. PubMed
  103. Evans H, et al. 2015. J Immunol. 195: 2973 - 2984. PubMed
  104. Cardona S, et al. 2015. ASN Neuro. 7: 1759091415608204. PubMed
  105. Zhu S, et al. 2022. Front Pharmacol. 13:996635. PubMed
  106. Palacios LM, et al. 2022. Biology (Basel). 11:. PubMed
  107. Kashyap AS, et al. 2019. Cell Rep. 28:3367. PubMed
  108. Pluchino N, et al. 2020. J Cell Mol Med. 24:2464. PubMed
  109. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  110. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  111. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  112. Adrover JM, et al. 2022. JCI Insight. 7:. PubMed
  113. Steubing RD, et al. 2022. Brain Behav Immun Health. 24:100493. PubMed
  114. Lu H, et al. 2021. Autophagy. 17:2511. PubMed
  115. Kawashima N, et al. 2022. Nat Commun. 13:1624. PubMed
  116. Ebneter A, et al. 2017. Transl Vis Sci Technol. 10.1167/tvst.6.2.10. PubMed
  117. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  118. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  119. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  120. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  121. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  122. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  123. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  124. Baram T, et al. 2021. Cells. 10:. PubMed
  125. Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed
  126. Han Y, et al. 2020. Nat Commun. 11:1776. PubMed
  127. Zhou X, et al. 2022. Front Pharmacol. 13:887263. PubMed
  128. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  129. Haertel E, et al. 2018. Eur J Immunol. 48:1001. PubMed
  130. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  131. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  132. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  133. Biswas S, et al. 2021. Nature. 591:464. PubMed
  134. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  135. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  136. Khandelwal P, et al. 2013. PLoS One. 8:64193. PubMed
  137. Shibata K, et al. 2014. J Immunol. 192:2210. PubMed
  138. Mantia-Smaldone G, et al. 2014. Gynecol Oncol. 133:584. PubMed
  139. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  140. AR P, et al. 2016. Circ Res. 118: 400-409. PubMed
  141. Wiley CD, et al. 2019. JCI Insight. 4:e130056. PubMed
  142. Krasteva G, et al. 2011. Proc Natl Acad Sci U S A. 108:9478. PubMed
  143. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  144. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  145. Armaka M, et al. 2022. Genome Med. 14:78. PubMed
  146. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  147. Jung BG, et al. 2022. PLoS Pathog. 18:e1010454. PubMed
  148. Ganeshan K et al. 2019. Cell. 177(2):399-413 . PubMed
  149. Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed
  150. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  151. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  152. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  153. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  154. Chew W, et al. 2016. Nat Methods. 13: 868-874. PubMed
  155. Cordeiro O, et al. 2016. PLoS One. 11: 0151848. PubMed
  156. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  157. Huang B, et al. 2020. Cell. 179(5):1160-1176.e24.. PubMed
  158. Ning F, et al. 2019. J Exp Med. 216:1396. PubMed
  159. Schönfeld M, et al. 2021. Alcohol Clin Exp Res. 45:1980. PubMed
  160. Bhattacherjee A, et al. 2021. Mol Neurodegener. 16:19. PubMed
  161. Higashi AY, et al. 2019. J Am Soc Nephrol. 30:80. PubMed
  162. Lyons J, et al. 2018. Sci Signal. 11. PubMed
  163. Evans R, et al. 2019. Cell Rep. 27:1967. PubMed
  164. Hammond TR, et al. 2019. Immunity. 50:253. PubMed
  165. Bagayoko S, et al. 2021. PLoS Pathog. 17:e1009927. PubMed
  166. Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed
  167. Marangoni F, et al. 2021. Cell. . PubMed
  168. Wang LT, et al. 2021. STAR Protocols. 2(1):100337. PubMed
  169. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  170. Weiner AI, et al. 2019. NPJ Regen Med. 4:17. PubMed
  171. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  172. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  173. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  174. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  175. Donlan AN, et al. 2020. Anaerobe. 66:102275. PubMed
  176. Uher O, et al. 2021. Cancers (Basel). 13:. PubMed
  177. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  178. Commerford CD et al. 2018. Cell reports. . PubMed
  179. Zeng J, et al. 2019. Cell Rep. 27:549. PubMed
  180. Yousef H, et al. 2018. Bio Protoc. 8:22. PubMed
  181. Willingham SB, et al. 2018. Cancer Immunol Res. 6:1136. PubMed
  182. Liu M, et al. 2020. Cell Rep. 32:107990. PubMed
  183. Jeljeli M, et al. 2020. Cell Rep. 33:108325. PubMed
  184. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  185. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  186. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  187. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  188. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  189. Chun E, et al. 2020. Immunity. 51(5):871-884.e6.. PubMed
  190. Bahar Halpern K, et al. 2020. Nat Commun. 11:1936. PubMed
  191. Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed
  192. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  193. Mifflin L, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  194. Stewart JM, et al. 2020. ACS Biomater Sci Eng. 6:5941. PubMed
  195. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  196. Gao H, et al. 2021. Cells. 10:. PubMed
  197. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  198. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  199. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  200. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  201. Zhang X, et al. 2020. Elife. 9:00. PubMed
  202. Veremeyko T, et al. 2012. J Vis Exp. 65: 4097. PubMed
  203. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  204. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  205. Ali M, et al. 2022. JCI Insight. 7:. PubMed
  206. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  207. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  208. Ghandhi SA, et al. 2022. Sci Rep. 12:14124. PubMed
  209. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  210. Ayaub E,et al. 2017. Sci Rep.. 10.1038/s41598-017-13511-z. PubMed
  211. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  212. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  213. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  214. Oladiran O, et al. 2021. J Neuroinflammation. 77:18. PubMed
  215. Martina M, et al. 2014. J Vis Exp. 87: 51192. PubMed
  216. Hu Y, et al. 2022. J Nanobiotechnology. 20:417. PubMed
  217. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  218. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  219. Neuhöfer P, et al. 2021. Nature. 597:715. PubMed
  220. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  221. Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed
  222. Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed
  223. Selvaraj UM, et al. 2021. Brain Behav Immun. 95:502. PubMed
  224. Ying T, et al. 2021. Am J Physiol Endocrinol Metab. 320:E1148. PubMed
  225. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  226. Momin N, et al. 2022. Nat Commun. 13:109. PubMed
  227. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  228. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  229. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  230. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  231. McFarland AP, et al. 2021. Immunity. 54(6):1320-1337.e4. PubMed
  232. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  233. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  234. Abramowski P, et al. 2014. J Neuroimmunol. 274:111. PubMed
  235. Hoeksema M, et al. 2015. J Immunol. 194:3909. PubMed
  236. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  237. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  238. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  239. Yang Y, et al. 2022. Elife. 11:. PubMed
  240. Dhanwani R, et al. 2020. Sci Adv. 6:eaba3688. PubMed
  241. Tripathi H, et al. 2020. Stem Cell Rev Rep. 0.953472222. PubMed
  242. Cardenas JJ, et al. 2020. Methods Enzymol. 415:631. PubMed
  243. Gierut J, et al. 2015. Stem Cell Res. 15: 165-171. PubMed
  244. Seki T, et al. 2015. J Biochem. 158: 485 - 495. PubMed
  245. Haka A, et al. 2012. PLoS One. 7:e44823. PubMed
  246. Kaya B, et al. 2020. Cell Reports. 32(5):107979. PubMed
  247. Sztwiertnia I, et al. 2020. PLoS One. 15:e0233789. PubMed
  248. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  249. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  250. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  251. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  252. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  253. Clement CC, et al. 2021. Nat Commun. 12:4447. PubMed
  254. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  255. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  256. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  257. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  258. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  259. Camara A, et al. 2019. Immunity. 50:1467. PubMed
  260. Michaelis KA, et al. 2019. Brain Behav Immun. 82:338. PubMed
  261. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  262. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  263. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  264. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  265. Yu W, et al. 2022. Nat Commun. 13:3544. PubMed
  266. Veremeyko T, et al. 2019. J Neurosci Res. 97:162. PubMed
  267. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  268. Kim MY, et al. 2018. Cell. 173:1439. PubMed
  269. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  270. Favuzzi E, et al. 2021. Cell. 184(15):4048-4063.e32. PubMed
  271. DiToro D, et al. 2020. Immunity. 650:52. PubMed
  272. Stock M, et al. 2015. Osteoarthritis Cartilage. 23: 1221-1225. PubMed
  273. Draper D, et al. 2012. J Immunol. 188:5327. PubMed
  274. Hohsfield LA, et al. 2020. J Neuroinflammation. 0.902083333. PubMed
  275. Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed
  276. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  277. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  278. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  279. Wang X, et al. 2022. Front Immunol. 13:864984. PubMed
  280. Galani IE, et al. 2022. STAR Protoc. 3:101151. PubMed
  281. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  282. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  283. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  284. Selvaraj UM et al. 2018. Endocrinology. 159(11):3848-3859 . PubMed
  285. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  286. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  287. Ou YC, et al. 2020. ACS Nano. 1.035416667. PubMed
  288. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  289. Zelco A, et al. 2020. Front Cell Neurosci. 0.75625. PubMed
  290. Wang LT, et al. 2020. Cell Rep. 32:108188. PubMed
  291. Hadas R, et al. 2020. JCI Insight. 5:00. PubMed
  292. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  293. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  294. Ben-Moshe S, et al. 2019. Nat Metab. 1:899. PubMed
  295. Bhatt D, et al. 2021. J Exp Med. 218:. PubMed
  296. Lu Z, et al. 2021. J Clin Invest. 131:. PubMed
  297. Luo M, et al. 2021. J Immunol. 207:1683. PubMed
  298. Wakabayashi T et al. 2018. Cell stem cell. 22(3):384-397 . PubMed
  299. Kaiser T, et al. 2019. Eneuro. 6. PubMed
  300. El Agha E, et al. 2017. Cell Stem Cell. 1.014583333. PubMed
  301. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  302. Klein S, et al. 2016. J Cell Sci. 129: 2573 - 2585. PubMed
  303. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
  304. Yu L, et al. 2020. Nat Commun. 2.045833333. PubMed
  305. Liu X, et al. 2019. Mol Cancer Ther. 18:706. PubMed
  306. Pedicone C, et al. 2022. iScience. 25:104170. PubMed
  307. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  308. Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
  309. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  310. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  311. Milich LM, et al. 2021. J Exp Med. 218:. PubMed
  312. Kline JM, et al. 2021. J Biol Chem. :100373. PubMed
  313. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  314. Jiang P, et al. 2018. Nat Med. 24:1550. PubMed
  315. Wang X, et al. 2018. Nat Commun. 9:551. PubMed
  316. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  317. Starikova E, et al. 2021. Front Pharmacol. 12:667572. PubMed
  318. Yoldi G, et al. 2016. Cancer Res . 76: 5857 - 5869. PubMed
  319. Ling Y, et al. 2016. Pharmacol Res. S1043-6618(16)31329-9. PubMed
  320. Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
  321. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  322. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  323. Gago-Lopez N, et al. 2019. EMBO Mol Med. 11:e10697. PubMed
  324. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  325. Uluçkan ö, et al. 2020. Cell Reports. 29(4):844-859.e3.. PubMed
  326. Yan C, et al. 2022. NPJ Precis Oncol. 6:6. PubMed
  327. Phansalkar R, et al. 2021. Elife. 10:. PubMed
  328. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  329. Armaka M, et al. 2018. Nat Commun. 9:618. PubMed
  330. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
  331. Theurich S et al. 2017. Cell metabolism. 26(1):171-184 . PubMed
  332. Martin A, et al. 2018. Oncotarget. 9:28364. PubMed
  333. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  334. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  335. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  336. Morein D, et al. 2021. Cells. 10: . PubMed
  337. E O’Koren, R Mathew, D Saban 2016. Sci Rep. 6:20636. PubMed
  338. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  339. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  340. Seeling M, et al. 2013. Proc Natl Acad Sci U S A. 110:10729. PubMed
  341. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  342. Willemze RA, et al. 2019. Mol Med. 25:01:00. PubMed
  343. Fransén Pettersson N, et al. 2018. PLoS One. 13:e0203228. PubMed
  344. Peng V, et al. 2022. Nat Immunol. 23:619. PubMed
  345. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  346. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  347. Zhang X, et al. 2022. J Exp Clin Cancer Res. 41:246. PubMed
  348. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  349. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  350. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  351. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  352. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  353. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  354. Liu SS, et al. 2021. Immunity. :. PubMed
  355. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  356. Lux A, et al. 2014. Cell Rep. 10:236. PubMed
  357. Madsen P, et al. 2016. J Neurosci. 36: 5128 - 5143. PubMed
  358. Fox B, et al. 2016. PLoS One. 12: 1006189. PubMed
  359. Parker K, Horn L, Ostrand-Rosenberg S 2016. J Leukoc Biol. 100: 463 - 470.. PubMed
  360. Forte E, et al. 2020. Cell Rep. 30:3149. PubMed
  361. Wang J, et al. 2020. J Hematol Oncol. 0.610416667. PubMed
  362. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  363. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  364. Sebastian A, et al. 2021. Cells. 10:. PubMed
  365. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  366. Petriello MC, et al. 2018. Toxicol Sci. 162:548. PubMed
  367. Severe N et al. 2019. Cell Stem Cell. 25(4):570-583 . PubMed
  368. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  369. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  370. Dinh HQ, et al. 2020. Immunity. 53(2):319-334.e6. PubMed
  371. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  372. Cong L, et al. 2021. Breast Cancer Res. 23:51. PubMed
  373. De Micheli AJ, et al. 2020. Am J Physiol Cell Physiol. 319:C885. PubMed
  374. Sibler E, et al. 2021. Cells. 10:. PubMed
  375. Oladiran O, et al. 2021. Front Immunol. 12:720733. PubMed
  376. Campisi L, et al. 2016. Nat Immunol. 10.1038/ni.3512. PubMed
  377. Holzapfel B, et al. 2015. Biomaterials. 61: 103-114. PubMed
  378. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  379. Swanson WB, et al. 2021. Biomaterials. 272:120769. PubMed
  380. Hohsfield LA, et al. 2021. Elife. 10:. PubMed
  381. Sun D, et al. 2020. PLoS Pathog. 16:e1008361. PubMed
  382. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  383. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  384. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
  385. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  386. Parent AV, et al. 2021. Cell Reports. 36(7):109538. PubMed
  387. Ito Y, et al. 2021. Cell Reports. 35(4):109052. PubMed
  388. Ma Y, et al. 2021. Developmental Cell. 56(4):478-493.e11. PubMed
  389. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
RRID
AB_312980 (BioLegend Cat. No. 103115)
AB_312981 (BioLegend Cat. No. 103116)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
Go To Top Version: 3    Revision Date: 01/30/2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account